Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 9, 2017- Dr. Finck's Presentation Awarded Best Poster in Basic Science at APSA
Biostage, Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
May 5, 2017- Conference Call with Live Audio Webcast on Thursday, May 11th at 9:00 AM ET -
Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
May 1, 2017- Biostage to present on Monday, May 1 at 3:25 p.m. EDT -
Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
Apr 26, 2017
Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
-
Apr 18, 2017
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...
Apr 6, 2017- Preclinical results demonstrate potential of Company's Cellspan Esophageal Implant to facilitate esophageal regeneration after resection -Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...
Mar 28, 2017Biostage to present in the 3D Printing and BioEngineering panel on Thursday, March 30 at 2:30 PM ETBiostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Mar 16, 2017- Dr. La Francesca responsible for leading scientific and clinical advancement of Company's lead program, Cellspan esophageal implants, into human clinical trials before the end of 2017
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
Mar 9, 2017- 2016 marked by establishing a strong foundation on operational, clinical and regulatory fronts in anticipation of a transformational year aheadBiostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Mar 2, 2017Conference Call with Live Audio Webcast on Thursday, March 9th at 9:00 AM ET
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Feb 16, 2017
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Feb 10, 2017
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Jan 6, 2017- Presentation with Live Webcast on Monday, January 9th at 2:30 p.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Dec 6, 2016- CEO, Jim McGorry, to participate in presentation and panel discussion on Wednesday, December 7th at 2:00 PM ET -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Dec 1, 2016
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 22, 2016- No immediate effect on the Company's Nasdaq listing or the trading of its common stock -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 10, 2016- Growing body of proof-of-concept preclinical data from ongoing studies continue to be replicated to show clear pattern of regeneration
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 3, 2016- Conference Call with Live Audio Webcast on Thursday, November 10 at 9:00 a.m. ET -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Oct 6, 2016-- Substantive pre-IND meeting with FDA provides clarity for clinical pathway of the Company's novel Cellspan Esophageal Implant --
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Sep 29, 2016- Presentation on Thursday, October 6th at 3:15 p.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Sep 14, 2016- Presentation with Live Webcast on Wednesday, September 21 at 11:30 a.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 24, 2016- Presentation with Live Webcast on Monday, September 12 at 3:00 p.m. EDT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 22, 2016- Recipient of NI Engineering Impact Award for Advanced Research in Regenerating and Restoring Organ Function Damaged by Disease or Trauma -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 11, 2016- Q2 marked by positive, confirmatory proof-of-concept results in large-animal studies of proprietary Cellspan™ technology and manuscript with Mayo Clinic being finalized for publication
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Jul 28, 2016
Biostage, Inc. (NASDAQ: BSTG) a biotechnology company developing bioengineered organ implants for life-threatening conditions of the esophagus, trachea and bronchus, will host a conference call on...
